Generex Biotechnology Corporation – Product Pipeline Review – Q1 2011 by GlobalMarketsDirect

VIEWS: 9 PAGES: 96

More Info
									            Generex Biotechnology Corporation – Product
                     Pipeline Review – Q1 2011
                                                                                          Reference Code: GMDHC1012CDB

                                                                                               Publication Date: MAR 2011




Generex Biotechnology Corporation – Product Pipeline Review – Q1 2011                       GMDHC1012CDB / Published MAR 2011

© Global Markets Direct. This report is a licensed product and is not to be photocopied                               Page(1)
Generex Biotechnology Corporation – Product Pipeline Review




Ta b le o f Co n te n ts
Table of Contents                                                                                                     2
List of Tables                                                                                                        5
List of Figures                                                                                                       5
Generex Biotechnology Corporation Snapshot                                                                            6
    Generex Biotechnology Corporation Overview                                                                        6
    Key Information                                                                                                   6
    Key Facts                                                                                                         6
Generex Biotechnology Corporation – Research and Development Overview                                                 7
    Key Therapeutic Areas                                                                                             7
Generex Biotechnology Corporation – Pipeline Review                                                                   9
    Pipeline Products by Stage of Development                                                                         9
    Pipeline Products – Monotherapy                                                                                  10
    Pipeline Products – Combination Treatment Modalities                                                             11
Generex Biotechnology Corporation – Pipeline Products Glance                                                         12
    Generex Biotechnology Corporation Clinical Stage Pipeline Products                                               12
         Phase II Products/Combination Treatment Modalities                                                          12
         Phase I Products/Combination Treatment Modalities                                                           13
    Generex Biotechnology Corporation–Early Stage Pipeline Products                                                  14
         Pre-Clinical Products/Combination Treatment Modalities                                                      14
Generex Biotechnology Corporation – Drug Profiles                                                                    15
    AE37 + Herceptin                                                                                                 15
         Product Description                                                                                         15
         Mechanism of Action                                                                                         15
         R&D Progress                                                                                                15
    Metcontrol Metformin Gum                                                                                         16
         Product Description                                                                                         16
         Mechanism of Action                                                                                         16
         R&D Progress                                                                                                16
    AE-AI Vaccine                                                                                                    17
         Product Description                                                                                         17
         Mechanism of Action                                                                                         17
         R&D Progress                                                                                                17
    AE-H Vaccine                                                                                                     18
         Product Description                                                                                         18
         Mechanism of Action                                                                                         18
         R&D Progress                                                                                                18
    AE-IG Vaccine                                                                                                    19
         Product Description                                                                                         19
         Mechanism of Action                                                                                         19
         R&D Progress                                                                                                19
    AE-M Vaccine                                                                                                     20
         Product Description                                                                                         20
         Mechanism of Action                                                                                         20
         R&D Progress                                                                                                20
    AE-O Vaccine                                                                                                     21
         Product Description                                                                                         21




Generex Biotechnology Corporation – Product Pipeline Review – Q1 2011                     GMDHC1012CDB / Published MAR 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                             Page(2)
Generex Biotechnology Corporation – Product Pipeline Review



         Mechanism of Action                                                                                                        21
         R&D Progress                                                                                                               21
    Fentanyl Oral Spray                                                                                                             22
         Product Description                                                                                                        22
         Mechanism of Action                                                                                                        22
         R&D Progress                                                                                                               22
    LMW Heparin Spray                                                                                                               23
         Product Description                                                                                                        23
         Mechanism of Action                                                                                                        23
         R&D Progress                                                                                                               23
    Morphine Oral Spray                                                                                                             24
         Product Description                                                                                                        24
         Mechanism of Action                                                                                                        24
         R&D Progress                                                                                                               24
    AE37                                                                                                                            25
         Product Description                                                                                                        25
         Mechanism of Action                                                                                                        25
         R&D Progress                                                                                                               25
Generex Biotechnology Corporation – Pipeline Analysis                                                                               27
    Generex Biotechnology Corporation – Pipeline Products by Therapeutic Class                                                      27
    Generex Biotechnology Corporation - Pipeline Products By Target                                                                 28
    Generex Biotechnology Corporation – Pipeline Products by Route of Administration                                                29
    Generex Biotechnology Corporation – Pipeline Products by Molecule Type                                                          30
Generex Biotechnology Corporation – Recent Pipeline Updates                                                                         31
Generex Biotechnology Corporation – Company Statement                                                                               32
Generex Biotechnology Corporation – Locations And Subsidiaries                                                                      36
    Head Office                                                                                                                     36
    Other Locations & Subsidiaries                                                                                                  36
Recent Developments                                                                                                                 37
         Dec 13, 2010: Generex Announces Publication Of New Positive Generex Oral-lyn Data In Peer-Reviewed Journal                 37
         Dec 06, 2010: Generex Presents New Positive AE37 Phase II Breast Cancer Vaccine Data At Annual San Antonio Breast Cancer
         Symposium                                                                                                                  38
         Sep 22, 2010: Generex Presents Abstract On Generex Oral-Lyn At EASD Annual Meeting                                         38
         Sep 14, 2010: Generex Signs Distribution Agreement For Generex Oral-lyn In Chile                                           38
         Sep 14, 2010: Generex Signs Distribution Agreement For Generex Oral-lyn In Chile                                           39
         Jul 28, 2010: Generex Reports Positive Update On Pivotal Phase III Trial Of Generex Oral-Lyn                               39
         Jul 28, 2010: Generex Reports Positive Update On Pivotal Phase III Trial Of Generex Oral-Lyn                               40
         Jul 13, 2010: Generex Oncology Granted US Patent For AE37 Peptide Vaccine                                                  40
         May 26, 2010: Generex Biotechnology To Participate In American Society Of Clinical Oncology Annual Meeting In Chic         40
         May 18, 2010: Generex Announces Publication Of Immunotherapeutic Cancer Vaccine Results In Patients With Prostate Cancer   41
Financial Deals Landscape                                                                                                           42
    Generex Biotechnology Corporation, Deals Volume Summary, 2004 to YTD 2011                                                       42
    Generex Biotechnology Corporation, Deals Summary By Region, 2004 to YTD 2011                                                    43
    Generex Biotechnology Corporation, Deals Summary, 2004 to YTD 2011                                                              44
    Generex Biotechnology Corporation Detailed Deal Summary                                                                         47
         Acquisition                                                                                                                47
         EnBW Acquires Offshore Ostsee Wind And Eos Offshore                                                                        47
         WPD Acquires Stake In Independent Power                                                                                    49




Generex Biotechnology Corporation – Product Pipeline Review – Q1 2011                                   GMDHC1012CDB / Published MAR 2011

©Global Markets Direct.. This report is a licensed product and is not to be photocopied                                             Page(3)
Generex Biotechnology Corporation – Product Pipeline Review



         Equity Offering                                                                                                           50
         Generex Completes Registered Direct Offering Of $12 Million                                                               50
         Generex Biotechnology Completes Registered Direct Offering For $5.65 Million                                              52
         Generex Biotechnology Completes Registered Direct Offering Of $10 Million                                                 54
         Generex Biotechnology Completes Registered Direct Offering For $5 Million                                                 56
         Generex Biotechnology Completes Private Placement Of $7 Million                                                           58
         Generex Biotechnology Completes Private Placement Of Warrants For $6 Million                                              60
         Generex Completes Private Placement Of $2 Million                                                                         62
         Generex Biotechnology Completes Private Placement Warrants For $11 Million                                                64
         Generex Biotechnology Completes Private Placement Of Warrants For $6 Million                                              66
         Generex Biotechnology Completes Private Placement Of $3 Million                                                           68
         Generex Biotechnology Completes Private Placement Of $2 Million                                                           69
         Generex Biotechnology Completes Private Placement Of $2 Million                                                           70
         Debt Offering                                                                                                             71
         Generex Completes Private Placement Of 8% Secured Convertible Notes For $21 Million                                       71
         Generex Completes Private Placement Of 6% Debentures For $4 Million                                                       72
         Generex Completes 
								
To top